Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.660
-0.160 (-4.19%)
At close: May 4, 2026, 4:00 PM EDT
3.590
-0.070 (-1.91%)
After-hours: May 4, 2026, 7:47 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $241.83 million as of May 4, 2026. Its market cap has increased by 224.89% in one year.
Market Cap
241.83M
Enterprise Value
172.24M
1-Year Change
224.89%
Ranking
Category
Stock Price
$3.66
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $241.83M, a decrease of -69.93%. That is a compound annual growth rate of -20.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 252.40M | 183.34% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 266.94M |
| Minerva Neurosciences | 266.12M |
| Alector | 260.46M |
| Cybin | 257.68M |
| Compugen | 256.24M |
| Sol-Gel Technologies | 247.17M |
| Arcturus Therapeutics Holdings | 245.29M |
| SAB Biotherapeutics | 243.86M |